TY - JOUR
T1 - Changes of antigen expression on human hepatoma cell lines caused by sodium butyrate, a differentiation inducer
AU - Saito, Hidetsugu
AU - Tada, Shinichiro
AU - Ebinuma, Hirotoshi
AU - Tsunematsu, Satoshi
AU - Kagawa, Tatehiro
AU - Kumagai, Naoki
AU - Inagaki, Yasutaka
AU - Watanabe, Tetsu
AU - Tsuchimoto, Kanji
AU - Morizane, Toshio
AU - Ishii, Hiromasa
AU - Tsuchiya, Masaharu
PY - 1994/12/1
Y1 - 1994/12/1
N2 - We have previously reported the effect of a differentiation inducer, sodium butyrate (SB), on human hepatocellular carcinoma (HCC) cell lines, demonstrating that it was a potent inducer of differentiation. In the present study, we investigated the alteration in expression of an antigen defined by a murine monoclonal antibody, H2, as well as alterations in the expression of other antigens, on the HCC cell lines HCC-T, HCC-M, and PLC/PRF/5, since it is known that specific antigenic changes occur during the differentiation of leukemic cells. The expression of the antigen defined by H2 increased immunocytochemically on HCC-T, HCC-M, and PLC/PRF/5 during treatment with SB. A flowcytometric study showed that almost all the HCC-T and HCC-M cells treated with SB highly expressed this antigen after 5 days' treatment. The antigen expression detected by H2 decreased after the removal of SB from the medium. On the other hand, antigen expression detected by another monoclonal antibody, 5C11, was not changed by this treatment. The expression of intracellular adhesion molecule (ICAM)-1 in HCC-T increased slightly, but that of β2-microglobulin and HLA-DR did not change. These results demonstrated that some antigen expression was changed by SB treatment and that the antigen defined by H2 seemed to be highly expressed on human HCC cells in the differentiated state.
AB - We have previously reported the effect of a differentiation inducer, sodium butyrate (SB), on human hepatocellular carcinoma (HCC) cell lines, demonstrating that it was a potent inducer of differentiation. In the present study, we investigated the alteration in expression of an antigen defined by a murine monoclonal antibody, H2, as well as alterations in the expression of other antigens, on the HCC cell lines HCC-T, HCC-M, and PLC/PRF/5, since it is known that specific antigenic changes occur during the differentiation of leukemic cells. The expression of the antigen defined by H2 increased immunocytochemically on HCC-T, HCC-M, and PLC/PRF/5 during treatment with SB. A flowcytometric study showed that almost all the HCC-T and HCC-M cells treated with SB highly expressed this antigen after 5 days' treatment. The antigen expression detected by H2 decreased after the removal of SB from the medium. On the other hand, antigen expression detected by another monoclonal antibody, 5C11, was not changed by this treatment. The expression of intracellular adhesion molecule (ICAM)-1 in HCC-T increased slightly, but that of β2-microglobulin and HLA-DR did not change. These results demonstrated that some antigen expression was changed by SB treatment and that the antigen defined by H2 seemed to be highly expressed on human HCC cells in the differentiated state.
KW - differentiation
KW - hepatocellular carcinoma
KW - liver-specific antigen
KW - monoclonal antibody
KW - sodium butyrate
UR - http://www.scopus.com/inward/record.url?scp=0028605888&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028605888&partnerID=8YFLogxK
U2 - 10.1007/BF02349279
DO - 10.1007/BF02349279
M3 - Article
C2 - 7874268
AN - SCOPUS:0028605888
SN - 0944-1174
VL - 29
SP - 733
EP - 739
JO - Journal of Gastroenterology
JF - Journal of Gastroenterology
IS - 6
ER -